At Serán, Our mission is to provide optimized drug development and manufacturing services for our clients, from discovery to the clinic. Our science-driven approach utilizes predictive design tools, novel chemistry, analytical tools, enabling delivery technologies, and a thorough knowledge of quality and regulatory requirements to guide our customers on their clinical development path. Serán’s team are experts in delivery of poorly soluble compounds. Serán employs a range of novel technologies and pharmaceutical manufacturing operations to overcome drug development challenges for both small and large molecules, including complex granulations, spray-dried dispersions, hot melt extrudates, IR and MR tablet technologies, multiparticulates, and engineered particles for inhalation. Our custom-built spray driers enable a wide variety of particle formation, from nano-structures to micro-particulates. Our particle engineering approaches are combined with our broad expertise in solid dosage forms resulting in the optimum clinical trial materials for your drug, including suspensions, capsules, and tablets.
Looking for a particular Serán BioScience employee's phone or email?
The Serán BioScience annual revenue was $7.3 million in 2026.
Dan Smithey is the President, CEO and Founder of Serán BioScience.
148 people are employed at Serán BioScience.
Serán BioScience is based in Bend, Oregon.
The NAICS codes for Serán BioScience are [325, 32541, 32, 3254].
The SIC codes for Serán BioScience are [283, 28].